- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ATAI Life Sciences BV (ATAI)
NASDAQ
Currency in USD
Disclaimer
1.100
+0.020(+1.85%)
Closed
After Hours
1.090-0.010(-0.909%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.030
1.110
52 wk Range
1.025
2.850
ATAI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ATAI Life Sciences BV stock price live, this page displays NASDAQ ATAI stock exchange data. View the ATAI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ATAI Life Sciences BV real time stock price chart below.
What Is the ATAI Life Sciences BV Stock Price Today?
The ATAI Life Sciences BV stock price today is 1.100.
What Is the Stock Symbol for ATAI Life Sciences BV?
The stock ticker symbol for ATAI Life Sciences BV is ATAI.
Is ATAI the Same as $ATAI?
$ATAI is a common way to refer to the ATAI Life Sciences BV ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ATAI Life Sciences BV Trade On?
ATAI Life Sciences BV is listed and trades on the NASDAQ stock exchange.
Is ATAI Life Sciences BV a Good Stock to Buy?
Determining whether ATAI Life Sciences BV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ATAI Life Sciences BV share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATAI quote. (ISIN: NL0015000DX5)
What Is the ATAI Life Sciences BV Stock Price Today?
The ATAI Life Sciences BV stock price today is 1.100.
What Is the Stock Symbol for ATAI Life Sciences BV?
The stock ticker symbol for ATAI Life Sciences BV is ATAI.
Is ATAI the Same as $ATAI?
$ATAI is a common way to refer to the ATAI Life Sciences BV ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ATAI Life Sciences BV Trade On?
ATAI Life Sciences BV is listed and trades on the NASDAQ stock exchange.
Is ATAI Life Sciences BV a Good Stock to Buy?
Determining whether ATAI Life Sciences BV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ATAI Life Sciences BV share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ATAI quote. (ISIN: NL0015000DX5)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0301.110
52 wk Range
1.0252.850
UnlockATAI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
9.250
Upside
+740.909%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
ATAI Life Sciences BV Company Profile
Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its product candidates include COMP360, a proprietary psilocybin which is in Phase 3 program; BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, an transmucosal film in Phase 1b clinical studies; and ELE-101, a serotonergic psychedelic that is in Phase 1/2a study, for the treatment of treatment resistant depression. The company also develop IBX-210, an intravenous formulation of ibogaine, and DMX-1002, an oral formulation of ibogaine indicated for the treatment of opioid use disorder; EMP-01, an oral formulation of an R-MDMA derivative being developed for the treatment of post-traumatic stress disorder; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, it offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, a deuterated etifoxine for the treatment of generalize anxiety disorder. Further, the company develops PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; KUR-101, a formulation of deuterated mitragynine for the treatment of OUD; and RLS-01, indicated for treatment resistant depression. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.
Compare ATAI to Peers and Sector
Metrics to compare | ATAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | −2.6x | −0.6x | |
PEG Ratio | −0.05 | −0.01 | 0.00 | |
Price / Book | 1.1x | 1.3x | 2.6x | |
Price / LTM Sales | 488.3x | 1.2x | 3.2x | |
Upside (Analyst Target) | - | 54.8% | 43.9% | |
Fair Value Upside | Unlock | 12.3% | 7.8% | Unlock |
People Also Watch
FAQ
What Is the ATAI Life Sciences BV (ATAI) Stock Price Today?
The ATAI Life Sciences BV stock price today is 1.10
What Stock Exchange Does ATAI Life Sciences BV Trade On?
ATAI Life Sciences BV is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for ATAI Life Sciences BV?
The stock symbol for ATAI Life Sciences BV is "ATAI."
What Is the ATAI Life Sciences BV Market Cap?
As of today, ATAI Life Sciences BV market cap is 184.58M.
What is ATAI Life Sciences BV Earnings Per Share?
The ATAI Life Sciences BV EPS is -0.361.
What Is the Next ATAI Life Sciences BV Earnings Date?
ATAI Life Sciences BV will release its next earnings report on Mar 27, 2025.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.